Logo image of DCBO

DOCEBO INC (DCBO) Stock Fundamental Analysis

NASDAQ:DCBO - Nasdaq - CA25609L1058 - Common Stock - Currency: USD

41.95  -0.89 (-2.08%)

After market: 41.95 0 (0%)

Fundamental Rating

6

Overall DCBO gets a fundamental rating of 6 out of 10. We evaluated DCBO against 286 industry peers in the Software industry. DCBO has only an average score on both its financial health and profitability. DCBO is not priced too expensively while it is growing strongly. Keep and eye on this one! With these ratings, DCBO could be worth investigating further for growth investing!.


Dividend Valuation Growth Profitability Health

6

1. Profitability

1.1 Basic Checks

DCBO had positive earnings in the past year.
In the past year DCBO had a positive cash flow from operations.
In multiple years DCBO reported negative net income over the last 5 years.
The reported operating cash flow has been mixed in the past 5 years: DCBO reported negative operating cash flow in multiple years.
DCBO Yearly Net Income VS EBIT VS OCF VS FCFDCBO Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 0 5M -5M 10M -10M 15M

1.2 Ratios

Looking at the Return On Assets, with a value of 10.36%, DCBO belongs to the top of the industry, outperforming 87.81% of the companies in the same industry.
With an excellent Return On Equity value of 40.06%, DCBO belongs to the best of the industry, outperforming 95.34% of the companies in the same industry.
With an excellent Return On Invested Capital value of 25.70%, DCBO belongs to the best of the industry, outperforming 96.42% of the companies in the same industry.
Industry RankSector Rank
ROA 10.36%
ROE 40.06%
ROIC 25.7%
ROA(3y)-0.27%
ROA(5y)-4.49%
ROE(3y)0.71%
ROE(5y)-7.92%
ROIC(3y)N/A
ROIC(5y)N/A
DCBO Yearly ROA, ROE, ROICDCBO Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 0 100 200

1.3 Margins

DCBO has a better Profit Margin (8.63%) than 76.34% of its industry peers.
DCBO has a better Operating Margin (8.14%) than 74.19% of its industry peers.
DCBO's Gross Margin of 80.92% is amongst the best of the industry. DCBO outperforms 83.15% of its industry peers.
DCBO's Gross Margin has been stable in the last couple of years.
Industry RankSector Rank
OM 8.14%
PM (TTM) 8.63%
GM 80.92%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-0.3%
GM growth 5Y0.45%
DCBO Yearly Profit, Operating, Gross MarginsDCBO Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 0 20 -20 40 -40 60 80

6

2. Health

2.1 Basic Checks

The Return on Invested Capital (ROIC) is well above the Cost of Capital (WACC), so DCBO is creating value.
The number of shares outstanding for DCBO has been reduced compared to 1 year ago.
The number of shares outstanding for DCBO has been increased compared to 5 years ago.
The debt/assets ratio for DCBO is higher compared to a year ago.
DCBO Yearly Shares OutstandingDCBO Yearly Shares OutstandingYearly Shares Outstanding 2017 2018 2019 2020 2021 2022 2023 10M 20M 30M
DCBO Yearly Total Debt VS Total AssetsDCBO Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2017 2018 2019 2020 2021 2022 2023 50M 100M 150M 200M 250M

2.2 Solvency

An Altman-Z score of 5.91 indicates that DCBO is not in any danger for bankruptcy at the moment.
The Altman-Z score of DCBO (5.91) is better than 67.38% of its industry peers.
The Debt to FCF ratio of DCBO is 0.08, which is an excellent value as it means it would take DCBO, only 0.08 years of fcf income to pay off all of its debts.
The Debt to FCF ratio of DCBO (0.08) is better than 79.21% of its industry peers.
A Debt/Equity ratio of 0.01 indicates that DCBO is not too dependend on debt financing.
DCBO has a better Debt to Equity ratio (0.01) than 62.72% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.01
Debt/FCF 0.08
Altman-Z 5.91
ROIC/WACC2.67
WACC9.62%
DCBO Yearly LT Debt VS Equity VS FCFDCBO Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 0 50M 100M 150M 200M

2.3 Liquidity

DCBO has a Current Ratio of 1.13. This is a normal value and indicates that DCBO is financially healthy and should not expect problems in meeting its short term obligations.
The Current ratio of DCBO (1.13) is worse than 69.89% of its industry peers.
DCBO has a Quick Ratio of 1.13. This is a normal value and indicates that DCBO is financially healthy and should not expect problems in meeting its short term obligations.
DCBO has a Quick ratio of 1.13. This is in the lower half of the industry: DCBO underperforms 69.18% of its industry peers.
Industry RankSector Rank
Current Ratio 1.13
Quick Ratio 1.13
DCBO Yearly Current Assets VS Current LiabilitesDCBO Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2017 2018 2019 2020 2021 2022 2023 50M 100M 150M 200M 250M

8

3. Growth

3.1 Past

DCBO shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 1350.00%, which is quite impressive.
The Revenue has grown by 22.67% in the past year. This is a very strong growth!
The Revenue has been growing by 46.20% on average over the past years. This is a very strong growth!
EPS 1Y (TTM)1350%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%33.33%
Revenue 1Y (TTM)22.67%
Revenue growth 3Y42.18%
Revenue growth 5Y46.2%
Sales Q2Q%19.2%

3.2 Future

The Earnings Per Share is expected to grow by 89.74% on average over the next years. This is a very strong growth
DCBO is expected to show a strong growth in Revenue. In the coming years, the Revenue will grow by 24.36% yearly.
EPS Next Y619.67%
EPS Next 2Y227.69%
EPS Next 3Y141.97%
EPS Next 5Y89.74%
Revenue Next Year20.14%
Revenue Next 2Y17.16%
Revenue Next 3Y16.91%
Revenue Next 5Y24.36%

3.3 Evolution

Although the future Revenue growth is still strong, it is not able to hold up the even more excellent growth rate of the past years.
DCBO Yearly Revenue VS EstimatesDCBO Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 2032 200M 400M 600M 800M
DCBO Yearly EPS VS EstimatesDCBO Yearly EPS VS EstimatesYearly EPS VS Estimates 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 2032 0 1 2 3

6

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings ratio is 72.33, which means the current valuation is very expensive for DCBO.
The rest of the industry has a similar Price/Earnings ratio as DCBO.
Compared to an average S&P500 Price/Earnings ratio of 28.46, DCBO is valued quite expensively.
DCBO is valuated quite expensively with a Price/Forward Earnings ratio of 43.41.
Compared to the rest of the industry, the Price/Forward Earnings ratio of DCBO indicates a somewhat cheap valuation: DCBO is cheaper than 60.57% of the companies listed in the same industry.
DCBO's Price/Forward Earnings ratio indicates a rather cheap valuation when compared to the S&P500 average which is at 92.56.
Industry RankSector Rank
PE 72.33
Fwd PE 43.41
DCBO Price Earnings VS Forward Price EarningsDCBO Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 20 40 60 80

4.2 Price Multiples

Compared to the rest of the industry, the Enterprise Value to EBITDA ratio of DCBO indicates a somewhat cheap valuation: DCBO is cheaper than 65.95% of the companies listed in the same industry.
Based on the Price/Free Cash Flow ratio, DCBO is valued a bit cheaper than 63.44% of the companies in the same industry.
Industry RankSector Rank
P/FCF 51.15
EV/EBITDA 60.45
DCBO Per share dataDCBO EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 2 4 6

4.3 Compensation for Growth

The low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
The decent profitability rating of DCBO may justify a higher PE ratio.
DCBO's earnings are expected to grow with 141.97% in the coming years. This may justify a more expensive valuation.
PEG (NY)0.12
PEG (5Y)N/A
EPS Next 2Y227.69%
EPS Next 3Y141.97%

0

5. Dividend

5.1 Amount

No dividends for DCBO!.
Industry RankSector Rank
Dividend Yield N/A

DOCEBO INC

NASDAQ:DCBO (1/31/2025, 8:24:47 PM)

After market: 41.95 0 (0%)

41.95

-0.89 (-2.08%)

Chartmill FA Rating
GICS SectorInformation Technology
GICS IndustryGroupSoftware & Services
GICS IndustrySoftware
Earnings (Last)11-08 2024-11-08/bmo
Earnings (Next)N/A N/A
Inst Owners34.77%
Inst Owner Change0.2%
Ins Owners1.39%
Ins Owner ChangeN/A
Market Cap1.27B
Analysts81.25
Price Target39.19 (-6.58%)
Short Float %0.5%
Short Ratio0.91
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)-7.78%
Min EPS beat(2)-25.3%
Max EPS beat(2)9.75%
EPS beat(4)3
Avg EPS beat(4)1.44%
Min EPS beat(4)-25.3%
Max EPS beat(4)20.77%
EPS beat(8)6
Avg EPS beat(8)95.3%
EPS beat(12)9
Avg EPS beat(12)121.51%
EPS beat(16)11
Avg EPS beat(16)74.14%
Revenue beat(2)1
Avg Revenue beat(2)-0.08%
Min Revenue beat(2)-0.54%
Max Revenue beat(2)0.37%
Revenue beat(4)1
Avg Revenue beat(4)-0.44%
Min Revenue beat(4)-1.42%
Max Revenue beat(4)0.37%
Revenue beat(8)1
Avg Revenue beat(8)-0.8%
Revenue beat(12)1
Avg Revenue beat(12)-1.16%
Revenue beat(16)5
Avg Revenue beat(16)0%
PT rev (1m)-2.26%
PT rev (3m)-3.37%
EPS NQ rev (1m)0%
EPS NQ rev (3m)-3.57%
EPS NY rev (1m)0%
EPS NY rev (3m)-8.3%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)0.07%
Revenue NY rev (1m)0.07%
Revenue NY rev (3m)0.77%
Valuation
Industry RankSector Rank
PE 72.33
Fwd PE 43.41
P/S 6.06
P/FCF 51.15
P/OCF 48.78
P/B 28.15
P/tB 43.95
EV/EBITDA 60.45
EPS(TTM)0.58
EY1.38%
EPS(NY)0.97
Fwd EY2.3%
FCF(TTM)0.82
FCFY1.95%
OCF(TTM)0.86
OCFY2.05%
SpS6.92
BVpS1.49
TBVpS0.95
PEG (NY)0.12
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA 10.36%
ROE 40.06%
ROCE 34.54%
ROIC 25.7%
ROICexc N/A
ROICexgc N/A
OM 8.14%
PM (TTM) 8.63%
GM 80.92%
FCFM 11.85%
ROA(3y)-0.27%
ROA(5y)-4.49%
ROE(3y)0.71%
ROE(5y)-7.92%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-0.3%
GM growth 5Y0.45%
F-Score8
Asset Turnover1.2
Health
Industry RankSector Rank
Debt/Equity 0.01
Debt/FCF 0.08
Debt/EBITDA 0.02
Cap/Depr 39.28%
Cap/Sales 0.58%
Interest Coverage 250
Cash Conversion 129.34%
Profit Quality 137.36%
Current Ratio 1.13
Quick Ratio 1.13
Altman-Z 5.91
F-Score8
WACC9.62%
ROIC/WACC2.67
Cap/Depr(3y)41.09%
Cap/Depr(5y)58.95%
Cap/Sales(3y)0.74%
Cap/Sales(5y)1.08%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)1350%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%33.33%
EPS Next Y619.67%
EPS Next 2Y227.69%
EPS Next 3Y141.97%
EPS Next 5Y89.74%
Revenue 1Y (TTM)22.67%
Revenue growth 3Y42.18%
Revenue growth 5Y46.2%
Sales Q2Q%19.2%
Revenue Next Year20.14%
Revenue Next 2Y17.16%
Revenue Next 3Y16.91%
Revenue Next 5Y24.36%
EBIT growth 1Y680.14%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year1766.62%
EBIT Next 3Y216.54%
EBIT Next 5Y117.3%
FCF growth 1Y2734.54%
FCF growth 3Y60.46%
FCF growth 5YN/A
OCF growth 1Y39896.9%
OCF growth 3Y45.71%
OCF growth 5YN/A